1-(8-Bromofuro[2,3-f][1]benzofuran-4-yl)propan-2-amine [Bromo-DragonFLY]

Page 1

Reaxys

PubChem

eMolecules

Reactions (21)

Substances (7)

Structure

Citations (8)

Structure/Compound Data Reaxys Registry Number: 8209670

Type of Substance: heterocyclic Molecular Formula: C13H12BrNO2

Linear Structure Formula: C13H12BrNO2

Molecular Weight: 294.148

InChI Key: GIKPTWKWYXCBEC-UHFFFAOYSA-N

N° of preparations All Preps | All Reactions

Available Data

4 prep out of 4 reactions.

Identification Bioactivity (5)

1

Synthesize | Hide Details Find similar

Identification Substance Label (2) Label

Reference

1; BDFLY

Parker, Matthew A.; Kurrasch, Deborah M.; Nichols, David E.

Bioorganic and Medicinal Chemistry, 2008 , vol. 16, # 8 p. 4661 - 4669 Title/Abstract Full Text View citing articles Show Details

(+/-)-3, base

Parker, Matthew A.; Marona-Lewicka, Danuta; Lucaites, Virginia L.; Nelson, David L.; Nichols, David E.

Journal of Medicinal Chemistry, 1998 , vol. 41, # 26 p. 5148 - 5149 Title/Abstract Full Text View citing articles Show Details

Bioactivity Pharmacological Data (5)

N° of ref. 4


1 of 5

Comment (Pharmacological Data)

Bioactivities present

Reference

ALCON, INC.

Patent: WO2003/51352 A1, 2003 ; Title/Abstract Full Text Show Details

Parker, Matthew A.; Marona-Lewicka, Danuta; Lucaites, Virginia L.; Nelson, David L.; Nichols, David E.

Journal of Medicinal Chemistry, 1998 , vol. 41, # 26 p. 5148 - 5149 Title/Abstract Full Text View citing articles Show Details

Parker, Matthew A.; Kurrasch, Deborah M.; Nichols, David E.

Bioorganic and Medicinal Chemistry, 2008 , vol. 16, # 8 p. 4661 - 4669 Title/Abstract Full Text View citing articles Show Details

Blaazer, Antoni R.; Smid, Pieter; Kruse, Chris G.

ChemMedChem, 2008 , vol. 3, # 9 p. 1299 - 1309 Title/Abstract Full Text View citing articles Show Details

2 of 5

3 of 5

4 of 5

5 of 5

Effect (Pharmacological Data)

receptor; binding activity

Species or TestSystem (Pharmacological Data)

brain frontal cortex homogenate of Sprague-Dawley rat

Sex

male

Method (Pharmacological Data)

5-HT2A receptor binding assay; tissue homogenate, <3H>MDL 100,907 and title comp. incub. for 15 min at 37 deg C in a shaking water bath; vacuum filtration performed; radioactivity measured using liquid scintillation spectroscopy at 37percent efficiency

Further Details (Pharmacological Data)

non-specific binding was determined in the presence of cinanserin (10 μM); Ki: binding affinity

Type (Pharmacological Data)

Ki

Value of Type (Pharmacological Data)

0.23 nmol/l

Reference

Parker, Matthew A.; Kurrasch, Deborah M.; Nichols, David E.

Bioorganic and Medicinal Chemistry, 2008 , vol. 16, # 8 p. 4661 - 4669 Title/Abstract Full Text View citing articles Show Details

Effect (Pharmacological Data)

functional activity

Species or TestSystem (Pharmacological Data)

rat

Method (Pharmacological Data)

drug discrimination assay using rats trained to distinguish the 5-HT2A receptor agonist LSD from saline; rat behavior observed

Results

title comp. indirectly determined to be an agonist of 5-HT2A receptor

Reference

Parker, Matthew A.; Kurrasch, Deborah M.; Nichols, David E.

Bioorganic and Medicinal Chemistry, 2008 , vol. 16, # 8 p. 4661 - 4669 Title/Abstract Full Text View citing articles Show Details

Comment (Pharmacological Data)

in vitro ability to displace (Ki, nM) 5-HT2 agonist <125I>DOI at cloned human 5-HT2A (0.04), 5-HT2C (0.02) receptors and <3H>serotonin at cloned human 5-HT2B (0.19) receptors

Reference

Parker, Matthew A.; Marona-Lewicka, Danuta; Lucaites, Virginia L.; Nelson, David L.; Nichols, David E.

Journal of Medicinal Chemistry, 1998 , vol. 41, # 26 p. 5148 - 5149 Title/Abstract Full Text View citing articles Show Details

Comment (Pharmacological Data)

in vivo (rats, i.p.) effectivity in drug discrimination assay: ED50=22 nmol/kg (training drug: LSD) and 39 nmol/kg (training drug: DOI)

Reference

Parker, Matthew A.; Marona-Lewicka, Danuta; Lucaites, Virginia L.; Nelson, David L.; Nichols, David E.

Journal of Medicinal Chemistry, 1998 , vol. 41, # 26 p. 5148 - 5149 Title/Abstract Full Text View citing articles Show Details


Chemical Name: (S)-(+)-1-(8-bromobenzo[1,2-b;4,5-b']difuran-4-yl)-2-aminopropane

2

Reaxys Registry Number: 8844511

Type of Substance: heterocyclic Molecular Formula: C13H12BrNO2

Linear Structure Formula: C13H12BrNO2

Molecular Weight: 294.148

InChI Key: GIKPTWKWYXCBEC-ZETCQYMHSA-N

8 prep out of 8 reactions.

Identification Bioactivity (4)

Synthesize | Hide Details Find similar Chemical Names and Synonyms (S)-(+)-1-(8-bromobenzo[1,2-b;4,5-b']difuran-4-yl)-2-aminopropane Identification Substance Label (1) Label

Reference

(S)-6b, free base

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Derivative (1) Derivative

Reference

2-(8-bromo-benzo[1,2-b;4,5-b']difuran-4-yl)-1-methyl-ethylamine; hydrochloride

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Bioactivity Pharmacological Data (4) 1 of 4

2 of 4

Comment (Pharmacological Data)

Bioactivities present

Reference

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Effect (Pharmacological Data)

receptor; binding activity

Species or TestSystem (Pharmacological Data)

NIH-3T3 fibroblasts expressing rat 5-HT2A receptors

Kind of Dosing (Pharmacological Data)

as hydrochloride

Method (Pharmacological Data)

in vitro; competition binding assay; <3H>DOB used as radioligand; Tris buffer, pH 7.4; 25 deg C; 60 min; scintillation counting; nonspecific binding determined in the presence of 10 μM cinanserin

Further Details (Pharmacological Data)

DOB: 4-bromo-2,5-dimethoxyamphetamine

Type (Pharmacological Data)

Ki

Value of Type (Pharmacological

0.68 nmol/l

1


Data)

3 of 4

4 of 4

Reference

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Effect (Pharmacological Data)

receptor; binding activity

Species or TestSystem (Pharmacological Data)

NIH-3T3 fibroblasts expressing rat 5-HT2C receptors

Kind of Dosing (Pharmacological Data)

as hydrochloride

Method (Pharmacological Data)

in vitro; competition binding assay; <125I>DOI used as radioligand; Tris buffer, pH 7.4; 25 deg C; 60 min; scintillation counting; nonspecific binding determined in the presence of 10 μM mianserin

Type (Pharmacological Data)

Ki

Value of Type (Pharmacological Data)

0.25 nmol/l

Reference

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Effect (Pharmacological Data)

agonist

Species or TestSystem (Pharmacological Data)

NIH-3T3 fibroblasts expressing rat 5-HT2A receptors

Kind of Dosing (Pharmacological Data)

as hydrochloride

Method (Pharmacological Data)

in vitro; phosphoinositol hydrolysis study; cells labeled for 18-20 h in CRML medium containing <3H>myo-inositol; after pretreating cells with 10 μM pargyline for 15 min, cells were incubated with title comp. at 37 deg C for 30 min

Further Details (Pharmacological Data)

95percent O2/5percent CO2 atmosphere; <3H>inositol phosphates separated by LC and quantified by scintillation counting

Type (Pharmacological Data)

EC50

Value of Type (Pharmacological Data)

19 nmol/l

Results

percent max. 5-HT stimulation: 79percent

Reference

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Chemical Name: bromodragonfly

3

Reaxys Registry Number: 8844512

Type of Substance: heterocyclic Molecular Formula: C13H12BrNO2

Linear Structure Formula: C13H12BrNO2

Molecular Weight: 294.148

InChI Key: GIKPTWKWYXCBEC-SSDOTTSWSA-N

8 prep out of 9 reactions.

Identification Bioactivity (7)

3


Synthesize | Hide Details Find similar Chemical Names and Synonyms bromodragonfly, BDF, (R)-(-)-1-(8-bromobenzo[1,2-b;4,5-b']difuran-4-yl)-2-aminopropane, 2-amino-1-(8-bromobenzo[1,2-b:4,5-b']difuran-4yl)propane Identification Substance Label (2) Label

Reference

3; (R)Br DFly

Kurrasch-Orbaugh, Deborah M.; Watts, Val J.; Barker, Eric L.; Nichols, David E.

Journal of Pharmacology and Experimental Therapeutics, 2003 , vol. 304, # 1 p. 229 - 237 Title/Abstract Full Text View citing articles Show Details

(R)-6b, free base

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Derivative (1) Derivative

Reference

2-(8-bromo-benzo[1,2-b;4,5-b']difuran-4-yl)-1-methyl-ethylamine; hydrochloride

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Bioactivity Pharmacological Data (7) 1 of 7

2 of 7

Comment (Pharmacological Data)

Bioactivities present

Reference

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Kurrasch-Orbaugh, Deborah M.; Watts, Val J.; Barker, Eric L.; Nichols, David E.

Journal of Pharmacology and Experimental Therapeutics, 2003 , vol. 304, # 1 p. 229 - 237 Title/Abstract Full Text View citing articles Show Details

Smith, Graham; Cotton, Marcus S.; Wermuth, Urs D.; Boyd, Sue E.

Acta Crystallographica Section C: Crystal Structure Communications, 2010 , vol. 66, # 5 p. o252-o255 Title/Abstract Full Text View citing articles Show Details

Effect (Pharmacological Data)

agonist

Endpoint of Effect (Pharmacological Data)

arachidonic acid (AA) release

Species or TestSystem (Pharmacological Data)

NIH3T3 fibroblasts stably expressing 5-HT2A receptors

Concentration (Pharmacological Data)

0.0001 - 10 μmol/l

Method (Pharmacological Data)

cells labeled with <3H>AA for 4 h; washed three times with DMEM and incubated with title comp. for 30 min at 37 deg C; <3H>AA in medium counted

Further Details (Pharmacological Data)

5-HT = 5-hydroxytryptamine; DMEM = Dulbecco's modified Eagle's medium; control: without title comp.

Type (Pharmacological Data)

EC50

Value of Type (Pharmacological Data)

51E-3 nmol/l


3 of 7

Results

title comp. stimulated the <3H>AA accumulation conc.-dependently (table)

Reference

Kurrasch-Orbaugh, Deborah M.; Watts, Val J.; Barker, Eric L.; Nichols, David E.

Journal of Pharmacology and Experimental Therapeutics, 2003 , vol. 304, # 1 p. 229 - 237 Title/Abstract Full Text View citing articles Show Details

Effect (Pharmacological Data)

agonist

Endpoint of Effect (Pharmacological Data)

IPs accumulation

Species or TestSystem (Pharmacological Data)

NIH3T3 fibroblasts stably expressing 5-HT2A receptors

Concentration (Pharmacological Data)

0.001 - 10 μmol/l

Method (Pharmacological Data)

cells loaded with myo-<2-3H(N)>inositol and pretreated with 10 μmol/l pargyline and 10 mmol/l LiCl for 15 min at 37 deg C in CMRL-1066 media; then title comp. added for 30 min; <3H>IPs of cell lysate separated by ion-exchange chromatography and counted

Further Details (Pharmacological Data)

4 of 7

Type (Pharmacological Data)

EC50

Value of Type (Pharmacological Data)

2.7 nmol/l

Results

title comp. stimulated the <3H>IPs accumulation conc.-dependently (table)

Reference

Kurrasch-Orbaugh, Deborah M.; Watts, Val J.; Barker, Eric L.; Nichols, David E.

Journal of Pharmacology and Experimental Therapeutics, 2003 , vol. 304, # 1 p. 229 - 237 Title/Abstract Full Text View citing articles Show Details

Effect (Pharmacological Data)

receptor; binding activity

Endpoint of Effect (Pharmacological Data)

<125I>2,5-dimethoxy-4-iodoamphetamine (DOI) binding

Species or TestSystem (Pharmacological Data)

NIH3T3 fibroblasts stably expressing 5-HT2A receptors

Concentration (Pharmacological Data)

1E-05 - 10 μmol/l

Method (Pharmacological Data)

competition binding study; cells incubated with 2E-1 nmol/l <125I>DOI in the presence title comp. for 60 min at 25 deg C in Tris-EDTA buffer, pH 7.4; nonspecific binding determ. with 10 μmol/l cinanserin; filter-bound radioactivity counted

Further Details (Pharmacological Data)

5 of 7

5-HT = 5-hydroxytryptamine; IPs = a mixture of inositol mono- bis-, and triphosphate; control: without title comp.

5-HT = 5-hydroxytryptamine; control: without title comp.

Type (Pharmacological Data)

Ki

Value of Type (Pharmacological Data)

31E-2 nmol/l

Reference

Kurrasch-Orbaugh, Deborah M.; Watts, Val J.; Barker, Eric L.; Nichols, David E.

Journal of Pharmacology and Experimental Therapeutics, 2003 , vol. 304, # 1 p. 229 - 237 Title/Abstract Full Text View citing articles Show Details

Effect (Pharmacological Data)

receptor; binding activity

Species or Test-

NIH-3T3 fibroblasts expressing rat 5-HT2A receptors


System (Pharmacological Data)

6 of 7

7 of 7

Kind of Dosing (Pharmacological Data)

as hydrochloride

Method (Pharmacological Data)

in vitro; competition binding assay; <3H>DOB used as radioligand; Tris buffer, pH 7.4; 25 deg C; 60 min; scintillation counting; nonspecific binding determined in the presence of 10 μM cinanserin

Further Details (Pharmacological Data)

DOB: 4-bromo-2,5-dimethoxyamphetamine

Type (Pharmacological Data)

Ki

Value of Type (Pharmacological Data)

0.31 nmol/l

Reference

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Effect (Pharmacological Data)

receptor; binding activity

Species or TestSystem (Pharmacological Data)

NIH-3T3 fibroblasts expressing rat 5-HT2C receptors

Kind of Dosing (Pharmacological Data)

as hydrochloride

Method (Pharmacological Data)

in vitro; competition binding assay; <125I>DOI used as radioligand; Tris buffer, pH 7.4; 25 deg C; 60 min; scintillation counting; nonspecific binding determined in the presence of 10 μM mianserin

Type (Pharmacological Data)

Ki

Value of Type (Pharmacological Data)

0.11 nmol/l

Reference

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Effect (Pharmacological Data)

agonist

Species or TestSystem (Pharmacological Data)

NIH-3T3 fibroblasts expressing rat 5-HT2A receptors

Kind of Dosing (Pharmacological Data)

as hydrochloride

Method (Pharmacological Data)

in vitro; phosphoinositol hydrolysis study; cells labeled for 18-20 h in CRML medium containing <3H>myo-inositol; after pretreating cells with 10 μM pargyline for 15 min, cells were incubated with title comp. at 37 deg C for 30 min

Further Details (Pharmacological Data)

95percent O2/5percent CO2 atmosphere; <3H>inositol phosphates separated by LC and quantified by scintillation counting

Type (Pharmacological Data)

EC50

Value of Type (Pharmacological Data)

2.7 nmol/l

Results

percent max. 5-HT stimulation: 93percent


Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Reference

Reaxys Registry Number: 8874216

Type of Substance: heterocyclic Molecular Formula: C13H12BrNO2*ClH Linear Structure Formula: C13H12BrNO2*HCl Molecular Weight: 330.609

InChI Key: YDIDKNSMQNPNFC-FJXQXJEOSA-N 4

no reactions.

Identification Physical Data (2) Spectra (2) Bioactivity (1)

1

Synthesize | Hide Details Find similar

Identification Substance Label (1) Label

Reference

(S)-6b

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Physical Data Melting Point (1) Melting Point

Comment (Melting Point)

Reference

291 °C

Decomposition

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Optical Rotatory Power (1) Type (Optical Rotatory Power)

Concentration (Optical Rotatory Power)

Solvent (Optical Rotatory Power)

Optical Rotatory Power

Wavelength (Optical Rotatory Power)

[alpha]

0.005 g/100ml

dimethylformamide

20.8 deg

589 nm

Reference Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Spectra NMR Spectroscopy (2) Description (NMR Spectroscopy)

Nucleus (NMR Spectroscopy)

Coupling Nuclei

Solvents (NMR Spectroscopy)

Chemical shifts

1H

D2O

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

1H

1H

D2O

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Reference


Bioactivity Pharmacological Data (1) 1 of 1

Comment (Pharmacological Data)

Bioactivities present

Reference

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Reaxys Registry Number: 8874217

Type of Substance: heterocyclic Molecular Formula: C13H12BrNO2*ClH Linear Structure Formula: C13H12BrNO2*HCl Molecular Weight: 330.609

InChI Key: YDIDKNSMQNPNFC-OGFXRTJISA-N

no reactions.

Identification Physical Data (2) Spectra (2) Bioactivity (1)

1

5

Synthesize | Hide Details Find similar

Identification Substance Label (1) Label

Reference

(R)-6b

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Physical Data Melting Point (1) Melting Point

Comment (Melting Point)

Reference

290 °C

Decomposition

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Optical Rotatory Power (1) Type (Optical Rotatory Power)

Concentration (Optical Rotatory Power)

Solvent (Optical Rotatory Power)

Optical Rotatory Power

Wavelength (Optical Rotatory Power)

[alpha]

0.005 g/100ml

dimethylformamide

-20.1 deg

589 nm

Reference Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Spectra NMR Spectroscopy (2) Description (NMR Spectroscopy)

Nucleus (NMR Spectroscopy)

Chemical shifts

1H

Coupling Nuclei

Solvents (NMR Spectroscopy) D2O

Reference Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details


1H

1H

D2O

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Bioactivity Pharmacological Data (1) 1 of 1

Comment (Pharmacological Data)

Bioactivities present

Reference

Chambers; Kurrasch-Orbaugh; Parker; Nichols

Journal of Medicinal Chemistry, 2001 , vol. 44, # 6 p. 1003 - 1010 Title/Abstract Full Text View citing articles Show Details

Reaxys Registry Number: 24224863

Molecular Formula: C13H12BrNO2*ClH Linear Structure Formula: C13H12BrNO2*ClH Molecular Weight: 330.609

InChI Key: YDIDKNSMQNPNFC-UHFFFAOYSA-N

6

no reactions.

Bioactivity (1)

2

Physical Data (7) Spectra (2)

1

Synthesize | Hide Details Find similar

Bioactivity Pharmacological Data (1) 1 of 1

Comment (Pharmacological Data)

Bioactivities present

Reference

Parker, Matthew A.; Kurrasch, Deborah M.; Nichols, David E.

Bioorganic and Medicinal Chemistry, 2008 , vol. 16, # 8 p. 4661 - 4669 Title/Abstract Full Text View citing articles Show Details

Parker, Matthew A.; Marona-Lewicka, Danuta; Lucaites, Virginia L.; Nelson, David L.; Nichols, David E.

Journal of Medicinal Chemistry, 1998 , vol. 41, # 26 p. 5148 - 5149 Title/Abstract Full Text View citing articles Show Details

Chemical Name: 1-(8-bromobenzo[1,2-b:5,4-b']difuran-4-yl)propan-2-aminium 2-carboxy4,6-dinitrophenolate

7

Reaxys Registry Number: 21544966

CAS Registry Number: 1263415-19-5 Molecular Formula: C7H4N2O7*C13H12BrNO2

Linear Structure Formula: C7H4N2O7*C13H12BrNO2

Molecular Weight: 522.266

InChI Key: LOPKBAKGHBGWCV-OGFXRTJISA-N

Synthesize | Hide Details Find similar Chemical Names and Synonyms 1-(8-bromobenzo[1,2-b:5,4-b']difuran-4-yl)propan-2-aminium 2-carboxy-4,6-dinitrophenolate

1 prep out of 1 reactions.


Physical Data Melting Point (1) Melting Point

Reference

493 - 495 °C

Smith, Graham; Cotton, Marcus S.; Wermuth, Urs D.; Boyd, Sue E.

Acta Crystallographica Section C: Crystal Structure Communications, 2010 , vol. 66, # 5 p. o252-o255 Title/Abstract Full Text View citing articles Show Details

Crystal Phase (2) Description (Crystal Phase)

Reference

Crystal growth

Smith, Graham; Cotton, Marcus S.; Wermuth, Urs D.; Boyd, Sue E.

Acta Crystallographica Section C: Crystal Structure Communications, 2010 , vol. 66, # 5 p. o252-o255 Title/Abstract Full Text View citing articles Show Details

Dimensions of the unit cell

Smith, Graham; Cotton, Marcus S.; Wermuth, Urs D.; Boyd, Sue E.

Acta Crystallographica Section C: Crystal Structure Communications, 2010 , vol. 66, # 5 p. o252-o255 Title/Abstract Full Text View citing articles Show Details

Crystal Property Description (1) Colour & Other Properties

Reference

yellow

Smith, Graham; Cotton, Marcus S.; Wermuth, Urs D.; Boyd, Sue E.

Acta Crystallographica Section C: Crystal Structure Communications, 2010 , vol. 66, # 5 p. o252-o255 Title/Abstract Full Text View citing articles Show Details

Crystal System (1) Comment (Crystal System)

Reference

Crystal system given

Smith, Graham; Cotton, Marcus S.; Wermuth, Urs D.; Boyd, Sue E.

Acta Crystallographica Section C: Crystal Structure Communications, 2010 , vol. 66, # 5 p. o252-o255 Title/Abstract Full Text View citing articles Show Details

Interatomic Distances and Angles (1) Description

Reference

Interatomic distances and angles

Smith, Graham; Cotton, Marcus S.; Wermuth, Urs D.; Boyd, Sue E.

Acta Crystallographica Section C: Crystal Structure Communications, 2010 , vol. 66, # 5 p. o252-o255 Title/Abstract Full Text View citing articles Show Details

Space Group (1) Comment (Space Group)

Reference

Space group(s) given

Smith, Graham; Cotton, Marcus S.; Wermuth, Urs D.; Boyd, Sue E.

Acta Crystallographica Section C: Crystal Structure Communications, 2010 , vol. 66, # 5 p. o252-o255 Title/Abstract Full Text View citing articles Show Details

Spectra NMR Spectroscopy (2) Description (NMR Spectroscopy)

Nucleus (NMR Spectroscopy)

Solvents (NMR Spectroscopy)

Temperature (NMR Spectroscopy)

Frequency (NMR Spectroscopy)

Chemical shifts

1H

dimethylsulfoxided6

24.84 °C

400 MHz

Smith, Graham; Cotton, Marcus S.; Wermuth, Urs D.; Boyd, Sue E.

Acta Crystallographica Section C: Crystal Structure Communications, 2010 , vol. 66, # 5 p. o252-o255 Title/Abstract Full Text View citing articles Show Details

Chemical shifts

13C

dimethylsulfoxided6

24.84 °C

100 MHz

Smith, Graham; Cotton, Marcus S.; Wermuth, Urs D.; Boyd, Sue E.

Acta Crystallographica Section C: Crystal Structure Communications, 2010 , vol. 66, # 5 p. o252-o255 Title/Abstract Full Text View citing articles Show Details

Reference


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.